Robert W. Baird reissued their hold rating on shares of Cardinal Health, Inc. (NYSE:CAH) in a research report sent to investors on Sunday morning. They currently have a $73.00 price target on the stock.

Other equities analysts have also issued reports about the stock. BidaskClub lowered shares of Cardinal Health from a strong-buy rating to a buy rating in a research report on Tuesday, July 11th. Vetr upgraded shares of Cardinal Health from a hold rating to a buy rating and set a $77.92 price objective for the company in a research report on Tuesday, June 13th. ValuEngine lowered shares of Cardinal Health from a buy rating to a hold rating in a research report on Friday, June 2nd. Jefferies Group LLC restated a hold rating and issued a $77.00 price objective on shares of Cardinal Health in a research report on Thursday, July 27th. Finally, Zacks Investment Research upgraded shares of Cardinal Health from a strong sell rating to a hold rating in a research report on Tuesday, June 20th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus price target of $78.45.

Cardinal Health (NYSE CAH) opened at 67.50 on Friday. Cardinal Health has a 12 month low of $62.70 and a 12 month high of $84.88. The firm has a market capitalization of $21.36 billion, a PE ratio of 16.75 and a beta of 0.85. The stock has a 50 day moving average of $68.30 and a 200 day moving average of $75.04.

Cardinal Health (NYSE:CAH) last issued its earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.07. The firm had revenue of $32.97 billion during the quarter, compared to analyst estimates of $32.73 billion. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The company’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter last year, the business earned $1.14 earnings per share. On average, equities analysts predict that Cardinal Health will post $4.96 earnings per share for the current fiscal year.

WARNING: This story was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://www.dailypolitical.com/2017/09/18/cardinal-health-inc-cah-given-hold-rating-at-robert-w-baird.html.

The company also recently announced a quarterly dividend, which will be paid on Sunday, October 15th. Investors of record on Monday, October 2nd will be paid a $0.4624 dividend. This represents a $1.85 annualized dividend and a dividend yield of 2.74%. The ex-dividend date is Friday, September 29th. Cardinal Health’s payout ratio is 45.79%.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Bronfman E.L. Rothschild L.P. increased its stake in shares of Cardinal Health by 31.8% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock worth $123,000 after buying an additional 382 shares during the period. Advisory Services Network LLC increased its stake in shares of Cardinal Health by 18.4% in the second quarter. Advisory Services Network LLC now owns 1,739 shares of the company’s stock worth $136,000 after buying an additional 270 shares during the period. JFS Wealth Advisors LLC increased its stake in shares of Cardinal Health by 14.3% in the second quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock worth $152,000 after buying an additional 244 shares during the period. Dupont Capital Management Corp purchased a new position in shares of Cardinal Health in the second quarter worth $164,000. Finally, First Personal Financial Services increased its stake in shares of Cardinal Health by 127.5% in the second quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock worth $172,000 after buying an additional 1,238 shares during the period. 87.63% of the stock is currently owned by institutional investors.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.